Apomorphine Hydrochloride Patent Expiration
Apomorphine Hydrochloride is Used for managing 'off' episodes in patients with Parkinson's disease. It was first introduced by Mdd Us Operations Llc
Apomorphine Hydrochloride Patents
Given below is the list of patents protecting Apomorphine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Kynmobi | US10420763 | Sublingual apomorphine | Jun 11, 2030 | Sumitomo Pharma Am |
| Kynmobi | US10449146 | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa | Apr 19, 2036 | Sumitomo Pharma Am |
| Kynmobi | US10821074 | Sublingual and buccal film compositions | Aug 07, 2029 | Sumitomo Pharma Am |
| Kynmobi | US10888499 | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
Feb 14, 2022
(Expired) | Sumitomo Pharma Am |
| Kynmobi | US10959943 | Methods of treating Parkinson's disease by administration of apomorphine to an oral mucosa | Apr 19, 2036 | Sumitomo Pharma Am |
| Kynmobi | US11077068 | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
Feb 14, 2022
(Expired) | Sumitomo Pharma Am |
| Kynmobi | US11419769 | Sublingual films | Dec 16, 2031 | Sumitomo Pharma Am |
| Kynmobi | US8414922 | Sublingual films | Dec 16, 2031 | Sumitomo Pharma Am |
| Kynmobi | US8603514 | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
Apr 03, 2024
(Expired) | Sumitomo Pharma Am |
| Kynmobi | US8663687 | Film compositions for delivery of actives |
Feb 02, 2023
(Expired) | Sumitomo Pharma Am |
| Kynmobi | US8765167 | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
Feb 20, 2024
(Expired) | Sumitomo Pharma Am |
| Kynmobi | US8846074 | Sublingual films | Dec 16, 2031 | Sumitomo Pharma Am |
| Kynmobi | US9044475 | Sublingual apomorphine | Jun 11, 2030 | Sumitomo Pharma Am |
| Kynmobi | US9283219 | Sublingual films | Jun 11, 2030 | Sumitomo Pharma Am |
| Kynmobi | US9326981 | Sublingual apomorphine | Jun 11, 2030 | Sumitomo Pharma Am |
| Kynmobi | US9669019 | Sublingual apomorphine | Jun 11, 2030 | Sumitomo Pharma Am |
| Kynmobi | US9669021 | Sublingual apomorphine | Jun 11, 2030 | Sumitomo Pharma Am |
| Kynmobi | US9855221 | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
Feb 14, 2022
(Expired) | Sumitomo Pharma Am |
| Kynmobi | US9931305 | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
Feb 14, 2022
(Expired) | Sumitomo Pharma Am |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Apomorphine Hydrochloride Generics
Only one generic application has been filed for Apomorphine Hydrochloride.
Given below is the list of companies who have filed for Apomorphine Hydrochloride generic.
1. SAGE CHEMS
Sage Chemicals Inc has filed for 1 generic for Apomorphine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sage Chems.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG/3ML (10MG/ML) | injectable | Prescription | SUBCUTANEOUS | AP | Feb 23, 2022 |